Abstract
An improved process for the preparation of Paliperidone palmitate, an anti-psychotic drug substance, with an overall yield of >87.0% (including purification) and >99.9% purity. Process optimization was done based on design of experiments (DOE) concept. Isolated product meets all regulatory requirements and quality target product profile (QTPP). Formation and control of all possible impurities are also addressed.
